NCT05678309 Establishment of a Patient Library in Patients With Pruritus Sine Materia
| NCT ID | NCT05678309 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Brest |
| Condition | Pruritus |
| Study Type | OBSERVATIONAL |
| Enrollment | 175 participants |
| Start Date | 2023-06-16 |
| Primary Completion | 2033-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 175 participants in total. It began in 2023-06-16 with a primary completion date of 2033-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Very little is currently known about the pathophysiology of pruritus sine materia according to the etiology. The creation of this cohort should make it possible to improve our clinical and biological knowledge according to the etiology, by collecting blood, skin, feces, and clinical data.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of pruritus sine materia * Collection of consent * Adult Exclusion Criteria: \- Refusal to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05678309 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Pruritus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05678309 currently recruiting?
Yes, NCT05678309 is actively recruiting participants. Contact the research team at laurent.misery@chu-brest.fr for enrollment information.
Where is the NCT05678309 trial being conducted?
This trial is being conducted at Brest, France.
Who is sponsoring the NCT05678309 clinical trial?
NCT05678309 is sponsored by University Hospital, Brest. The trial plans to enroll 175 participants.